ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 98 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $169,158 | -48.1% | 25,323 | -34.8% | 0.00% | – |
Q2 2023 | $325,673 | +18.9% | 38,817 | +40.8% | 0.00% | – |
Q1 2023 | $273,840 | +163.6% | 27,577 | +84.7% | 0.00% | – |
Q4 2022 | $103,899 | +22.2% | 14,928 | -6.3% | 0.00% | – |
Q3 2022 | $85,000 | +9.0% | 15,928 | -18.2% | 0.00% | – |
Q2 2022 | $78,000 | -29.1% | 19,463 | -21.3% | 0.00% | – |
Q1 2022 | $110,000 | -20.3% | 24,742 | -28.4% | 0.00% | – |
Q4 2021 | $138,000 | -77.2% | 34,577 | -49.7% | 0.00% | -100.0% |
Q3 2021 | $604,000 | -4.4% | 68,788 | +23.3% | 0.00% | 0.0% |
Q2 2021 | $632,000 | -19.6% | 55,797 | -15.7% | 0.00% | 0.0% |
Q1 2021 | $786,000 | +25.6% | 66,191 | -27.4% | 0.00% | 0.0% |
Q4 2020 | $626,000 | -12.1% | 91,201 | -5.0% | 0.00% | 0.0% |
Q3 2020 | $712,000 | +49.3% | 96,031 | -16.0% | 0.00% | 0.0% |
Q2 2020 | $477,000 | +183.9% | 114,373 | +65.3% | 0.00% | – |
Q1 2020 | $168,000 | -63.6% | 69,210 | -12.8% | 0.00% | -100.0% |
Q4 2019 | $461,000 | +236.5% | 79,336 | +204.0% | 0.00% | – |
Q3 2019 | $137,000 | -55.8% | 26,100 | -49.4% | 0.00% | -100.0% |
Q2 2019 | $310,000 | +103.9% | 51,549 | +212.1% | 0.00% | – |
Q1 2019 | $152,000 | +72.7% | 16,519 | +53.6% | 0.00% | – |
Q4 2018 | $88,000 | -54.4% | 10,754 | -22.9% | 0.00% | -100.0% |
Q3 2018 | $193,000 | +127.1% | 13,954 | +32.7% | 0.00% | – |
Q2 2018 | $85,000 | +7.6% | 10,517 | +1.4% | 0.00% | – |
Q1 2018 | $79,000 | – | 10,367 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |